{"id":"acetylcarnitine","rwe":[],"tags":[{"label":"Carnitine Analog","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"N06BX12","category":"atc"},{"label":"Active","category":"status"},{"label":"Alzheimer's disease","category":"indication"},{"label":"Senile dementia","category":"indication"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Micronutrients","category":"pharmacology"},{"label":"Nootropic Agents","category":"pharmacology"},{"label":"Vitamin B Complex","category":"pharmacology"},{"label":"Vitamins","category":"pharmacology"}],"phase":"discontinued","safety":{"commonSideEffects":[],"contraindications":["Kidney disease","Seizure disorder"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"levocarnitine acetyl","offLabel":[],"synonyms":["acetylcarnitine","L-Acetylcarnitine","levocarnitine acetyl","O-Acetylcarnitine"],"timeline":[],"brandName":"Levocarnitine Acetyl","ecosystem":[{"indication":"Alzheimer's disease","otherDrugs":[{"name":"aducanumab","slug":"aducanumab","company":"Biogen Inc"},{"name":"donepezil","slug":"donepezil","company":"Eisai Inc"},{"name":"epicriptine","slug":"epicriptine","company":""},{"name":"galantamine","slug":"galantamine","company":"Janssen Pharms"}],"globalPrevalence":55000000},{"indication":"Senile dementia","otherDrugs":[{"name":"epicriptine","slug":"epicriptine","company":""}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"Carnitine Analog","explanation":"Think of it like a delivery truck bringing fuel to a power plant. Acetylcarnitine helps the truck (fatty acid transport) get the fuel (fatty acids) to the power plant (mitochondria) where it can be used to produce energy for the body.","oneSentence":"Acetylcarnitine works by supporting the transport of fatty acids into mitochondria, where they can be used for energy production.","technicalDetail":"Acetylcarnitine acts as a cofactor for the enzyme carnitine palmitoyltransferase, facilitating the transfer of long-chain fatty acids into the mitochondria, where they can undergo beta-oxidation and produce ATP."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/64","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ACETYLCARNITINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACETYLCARNITINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:23:37.106610","biosimilars":[],"competitors":[],"genericName":"acetylcarnitine","indications":{"approved":[{"name":"Alzheimer's disease","source":"DrugCentral","snomedId":26929004,"regulator":"FDA","usPrevalence":6700000,"globalPrevalence":55000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"},{"name":"Senile dementia","source":"DrugCentral","snomedId":15662003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05767515","phase":"NA","title":"The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2023-07-15","conditions":["Infertility, Female","PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries"],"enrollment":120,"completionDate":"2024-03-10"},{"nctId":"NCT06126315","phase":"PHASE2,PHASE3","title":"Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS","status":"RECRUITING","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2025-03-26","conditions":["Amyotrophic Lateral Sclerosis"],"enrollment":246,"completionDate":"2027-09"},{"nctId":"NCT06573229","phase":"NA","title":"LIver FRAilty Management IN Cirrhosis (LIFRAMIN)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-08-02","conditions":["Sarcopenia","Cirrhosis, Liver","Malnutrition; Protein"],"enrollment":30,"completionDate":"2025-10-30"},{"nctId":"NCT06247813","phase":"PHASE2","title":"Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain","status":"RECRUITING","sponsor":"Ethos Research & Development","startDate":"2024-02-08","conditions":["Chronic Pain"],"enrollment":75,"completionDate":"2025-07-30"},{"nctId":"NCT05284487","phase":"NA","title":"Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel.","status":"UNKNOWN","sponsor":"Welcare Industries SpA","startDate":"2023-03-27","conditions":["Radiation-induced Dermatitis"],"enrollment":57,"completionDate":"2024-03"},{"nctId":"NCT05653895","phase":"NA","title":"Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2022-12-07","conditions":["PCOS"],"enrollment":120,"completionDate":"2024-02-07"},{"nctId":"NCT06122012","phase":"NA","title":"To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China","status":"UNKNOWN","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2023-05-01","conditions":["Diabetic Peripheral Neuropathic Pain"],"enrollment":136,"completionDate":"2024-05"},{"nctId":"NCT06078163","phase":"NA","title":"Combined Rehabilitation With ALA, ALC, Resveratrol and Vitamin D in Discogenic Sciatica in Young People","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2022-07-01","conditions":["Sciatic Radiculopathy"],"enrollment":130,"completionDate":"2023-08-22"},{"nctId":"NCT06042738","phase":"NA","title":"Investigation of The Effectiveness of Antioxidant Therapy in Oligoasthenoteratozoospermic Infertile Men","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2021-03-01","conditions":["Male Infertility"],"enrollment":48,"completionDate":"2021-11-01"},{"nctId":"NCT05616000","phase":"PHASE2","title":"Comparison of Acetyl- L- Carnitine& Folic Acid Versus Coenzyme Q10& Folic Acid on Semen& Hormonal Parameters& Semen Oxidative Status in Patients of Primary Infertility. A Double Blind Randomized Clinical Trial","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2022-08-06","conditions":["Infertility"],"enrollment":86,"completionDate":"2022-11-29"},{"nctId":"NCT05601479","phase":"PHASE2","title":"Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2022-11-01","conditions":["Acetylcarnitine","Chemotherapy-induced Peripheral Neuropathy"],"enrollment":100,"completionDate":"2024-12-31"},{"nctId":"NCT04790188","phase":"NA","title":"Effect of a Nootropic on the Cognitive Performance in Young Adults","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2021-04-01","conditions":["Cognitive Change"],"enrollment":25,"completionDate":"2022-05-15"},{"nctId":"NCT01695317","phase":"PHASE4","title":"Effect of Acetyl-L-carnitine in Migraine","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2013-04","conditions":["Migraine"],"enrollment":72,"completionDate":"2014-09"},{"nctId":"NCT00050271","phase":"NA","title":"Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":["HIV Infections","Peripheral Nervous System Diseases"],"enrollment":27,"completionDate":"2007-01"},{"nctId":"NCT01054768","phase":"PHASE2","title":"Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease","status":"COMPLETED","sponsor":"UCSF Benioff Children's Hospital Oakland","startDate":"2009-08","conditions":["Anemia, Sickle Cell"],"enrollment":37,"completionDate":"2013-04"},{"nctId":"NCT02955706","phase":"PHASE4","title":"Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2016-04-01","conditions":["Alzheimer Disease"],"enrollment":265,"completionDate":"2019-01-25"},{"nctId":"NCT04623619","phase":"NA","title":"Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo","startDate":"2020-12-15","conditions":["Covid19"],"enrollment":100,"completionDate":"2021-07-31"},{"nctId":"NCT03697928","phase":"","title":"Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability","status":"COMPLETED","sponsor":"Maastricht University","startDate":"2019-03-12","conditions":["Metabolism and Nutrition Disorder","Metabolic Disturbance"],"enrollment":13,"completionDate":"2020-02-01"},{"nctId":"NCT04509258","phase":"PHASE4","title":"Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-10","conditions":["the Study Focus to Improve the Standard of Care Used for Aluminuim Phosphide Poisoning and to Save Patients With the Minimal Organ Damage"],"enrollment":100,"completionDate":"2021-12"},{"nctId":"NCT04346862","phase":"PHASE4","title":"Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease","status":"UNKNOWN","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2016-01-26","conditions":["Mild Cognitive Impairment"],"enrollment":636,"completionDate":"2020-06-30"},{"nctId":"NCT04113889","phase":"PHASE2","title":"Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2019-10-15","conditions":["PCOS"],"enrollment":147,"completionDate":"2020-01-30"},{"nctId":"NCT00581919","phase":"PHASE2","title":"Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2004-02","conditions":["Multiple Myeloma"],"enrollment":32,"completionDate":"2013-07"},{"nctId":"NCT04177667","phase":"NA","title":"Body Mass Index and Age Correlate With Antioxidant Supplementation Effects on Sperm Quality","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2014-12-01","conditions":["Male Infertility"],"enrollment":104,"completionDate":"2017-11-30"},{"nctId":"NCT03965819","phase":"NA","title":"A Study to Investigate the Efficacy of Pain Bloc-R in Healthy Participants With Non-pathological Aches and Discomfort","status":"COMPLETED","sponsor":"LifeSeasons Inc.","startDate":"2019-05-30","conditions":["Healthy"],"enrollment":27,"completionDate":"2019-08-09"},{"nctId":"NCT02835664","phase":"NA","title":"Nicotinamide Riboside and Metabolic Health","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2016-12","conditions":["Obesity","Insulin Resistance"],"enrollment":15,"completionDate":"2018-12"},{"nctId":"NCT02999958","phase":"NA","title":"Adding Antioxidants Into Human Sequential Culture Media System","status":"COMPLETED","sponsor":"Vitrolife","startDate":"2016-12","conditions":["Culture Media","Blastocyst","Antioxidants","Embryo","Human","Oxygen"],"enrollment":128,"completionDate":"2018-05"},{"nctId":"NCT01381354","phase":"PHASE1","title":"Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2010-10","conditions":["Multiple Sclerosis"],"enrollment":38,"completionDate":"2016-05"},{"nctId":"NCT02971878","phase":"NA","title":"Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of Antioxidants","status":"COMPLETED","sponsor":"Fertilitetscentrum AB","startDate":"2016-11","conditions":["Culture Media","Blastocyst","Antioxidants","Embryo","Human"],"enrollment":128,"completionDate":"2018-02-01"},{"nctId":"NCT00592488","phase":"PHASE1,PHASE2","title":"Acetyl-L-Carnitine in the Treatment of Septic Shock","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2006-08","conditions":["Septic Shock"],"enrollment":13,"completionDate":"2009-09"},{"nctId":"NCT02141035","phase":"PHASE2,PHASE3","title":"Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2015-09","conditions":["Carpal Tunnel Syndrome","Compression Neuropathy"],"enrollment":20,"completionDate":"2017-09"},{"nctId":"NCT00775645","phase":"PHASE3","title":"S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2009-09","conditions":["Breast Cancer","Chemotherapeutic Agent Toxicity","Fatigue","Neuropathy","Neurotoxicity"],"enrollment":437,"completionDate":"2013-06"},{"nctId":"NCT01537549","phase":"PHASE1,PHASE2","title":"Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2010-09-14","conditions":["Progressive Supranuclear Palsy"],"enrollment":11,"completionDate":"2015-04-07"},{"nctId":"NCT02538146","phase":"EARLY_PHASE1","title":"Effect of Acetyl-L-carnitine on Chronic Pancreatitis","status":"TERMINATED","sponsor":"Karin High","startDate":"2015-08","conditions":["Chronic Pancreatitis"],"enrollment":3,"completionDate":"2016-10"},{"nctId":"NCT02598622","phase":"PHASE2","title":"A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL","status":"TERMINATED","sponsor":"Indiana University","startDate":"2009-09","conditions":["Vincristine Induced Neuropathy"],"enrollment":8,"completionDate":"2016-01"},{"nctId":"NCT02891512","phase":"NA","title":"Very Low Frequency Magnetic Fields Versus the Supplement \"Xinepa\" in the Treatment of the Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2015-07","conditions":["Carpal Tunnel Syndrome"],"enrollment":31,"completionDate":"2016-01"},{"nctId":"NCT01872351","phase":"","title":"Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2011-11","conditions":["Chronic Fatigue Syndrome"],"enrollment":0,"completionDate":"2012-11"},{"nctId":"NCT01553968","phase":"NA","title":"Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2012-04","conditions":["Diabetes Mellitus, Type 2"],"enrollment":9,"completionDate":"2014-06"},{"nctId":"NCT02696512","phase":"PHASE1,PHASE2","title":"A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness","status":"UNKNOWN","sponsor":"International Brain Research Foundation","startDate":"2016-03","conditions":["Brain Injury"],"enrollment":30,"completionDate":"2017-04"},{"nctId":"NCT02072759","phase":"NA","title":"Acetylcarnitine and Metabolic Flexibility","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2014-03","conditions":["Glucose Intolerance"],"enrollment":24,"completionDate":"2016-06"},{"nctId":"NCT00572741","phase":"NA","title":"Treating Oxidative Stress and the Metabolic Pathology of Autism","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2008-06","conditions":["Autistic Disorder"],"enrollment":39,"completionDate":"2016-04"},{"nctId":"NCT01921868","phase":"NA","title":"An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia","status":"UNKNOWN","sponsor":"University of South Florida","startDate":"2013-08","conditions":["Friedreich's Ataxia"],"enrollment":20,"completionDate":"2017-06"},{"nctId":"NCT01320527","phase":"PHASE2","title":"A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-08","conditions":["Alzheimer's Disease","Mild Cognitive Impairment"],"enrollment":135,"completionDate":"2012-04"},{"nctId":"NCT01524861","phase":"PHASE4","title":"Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2011-12","conditions":["Apical Ballooning Syndrome","Nervous System Diseases, Sympathetic"],"enrollment":90,"completionDate":"2016-01"},{"nctId":"NCT01379976","phase":"PHASE3","title":"Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2011-04","conditions":["Non Small Cell Lung Cancer"],"enrollment":107,"completionDate":"2014-10"},{"nctId":"NCT01471652","phase":"PHASE2","title":"Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2012-03","conditions":["Chronic Fatigue Syndrome"],"enrollment":0,"completionDate":"2013-02"},{"nctId":"NCT01492920","phase":"PHASE3","title":"Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy","status":"WITHDRAWN","sponsor":"Gynecologic Oncology Group","startDate":"2012-04","conditions":["Fatigue","Malignant Ovarian Mixed Epithelial Tumor","Neuropathy","Neurotoxicity Syndrome","Ovarian Brenner Tumor","Ovarian Clear Cell Cystadenocarcinoma","Ovarian Endometrioid Adenocarcinoma","Ovarian Mucinous Cystadenocarcinoma","Ovarian Serous Cystadenocarcinoma","Pain","Recurrent Fallopian Tube Carcinoma","Recurrent Ovarian Carcinoma","Recurrent Primary Peritoneal Carcinoma"],"enrollment":0,"completionDate":""},{"nctId":"NCT00751205","phase":"PHASE2","title":"Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-08","conditions":["Prostate Cancer","Ovarian Cancer"],"enrollment":150,"completionDate":"2010-08"},{"nctId":"NCT02173132","phase":"PHASE3","title":"Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2010-04","conditions":["Work Stress","Work Ability","Work Performance"],"enrollment":94,"completionDate":""},{"nctId":"NCT01526564","phase":"PHASE3","title":"Clinical Study on Acetyl-L-Carnitine","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2008-08","conditions":["Peripheral Sensory Neuropathy"],"enrollment":239,"completionDate":"2011-07"},{"nctId":"NCT01913964","phase":"PHASE4","title":"Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin","status":"COMPLETED","sponsor":"University of Catania","startDate":"1997-10","conditions":["Work Productivity and Activity Impairment in Workers With Chronic C Hepatitis","Fatigue in Workers With Chronic C Hepatitis","Fatigue"],"enrollment":0,"completionDate":"1997-10"},{"nctId":"NCT01909557","phase":"PHASE3","title":"Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.","status":"COMPLETED","sponsor":"University of Catania","startDate":"2010-01","conditions":["Quality of Life","Daily Activity","Fatigue"],"enrollment":62,"completionDate":"2011-12"},{"nctId":"NCT00984750","phase":"PHASE3","title":"Acetyl-L-Carnitine in Type 2 Diabetes","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2008-04","conditions":["Diabetes Type 2","Hypertension"],"enrollment":229,"completionDate":"2012-12"},{"nctId":"NCT01752868","phase":"NA","title":"Can Fish Oil and Phytochemical Supplements Mimic Anti-Aging Effects of Calorie Restriction?","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2011-05","conditions":["Healthy Volunteers"],"enrollment":56,"completionDate":"2012-08"},{"nctId":"NCT00555841","phase":"PHASE2","title":"Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue","status":"TERMINATED","sponsor":"Sigma-Tau Research, Inc.","startDate":"2007-03","conditions":["Breast Cancer"],"enrollment":27,"completionDate":"2008-09"},{"nctId":"NCT00719706","phase":"PHASE2","title":"The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2008-08","conditions":["Bipolar Depression"],"enrollment":40,"completionDate":"2011-05"},{"nctId":"NCT00903695","phase":"PHASE2","title":"MemoryXL Effects on Mild Cognitive Impairment Patients","status":"TERMINATED","sponsor":"University of Oklahoma","startDate":"2009-06","conditions":["Mild Cognitive Impairment"],"enrollment":10,"completionDate":"2011-05"},{"nctId":"NCT01515839","phase":"NA","title":"Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players","status":"COMPLETED","sponsor":"Amen Clinics, Inc.","startDate":"2009-05","conditions":["Traumatic Brain Injury"],"enrollment":100,"completionDate":"2010-06"},{"nctId":"NCT00393770","phase":"PHASE2","title":"Acetylcarnitine and Insulin Sensitivity","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2004-02","conditions":["Type 2 Diabetes Mellitus"],"enrollment":43,"completionDate":"2007-09"},{"nctId":"NCT01223729","phase":"NA","title":"Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2002-04","conditions":["Minimal Hepatic Encephalopathy"],"enrollment":67,"completionDate":"2005-11"},{"nctId":"NCT01223768","phase":"NA","title":"Acetyl-L-Carnitine In Severe Hepatic Encephalopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2002-07","conditions":["Hepatic Encephalopathy (Grade 3 of the West Haven Grading Scale)"],"enrollment":0,"completionDate":"2005-12"},{"nctId":"NCT01223742","phase":"NA","title":"Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2002-06","conditions":["Hepatic Encephalopathy"],"enrollment":0,"completionDate":"2006-12"},{"nctId":"NCT01075334","phase":"NA","title":"Is a Carnitine Based Food Supplement (PorimoreTM) for Infertile Men Superior to Folate and Zinc With Regard to Pregnancy Rates in Intrauterine Insemination Cycles?","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2010-02","conditions":["Male Infertility"],"enrollment":100,"completionDate":"2012-12"},{"nctId":"NCT00225160","phase":"PHASE2","title":"ALCAR Prophylaxis Study","status":"UNKNOWN","sponsor":"Royal Free Hampstead NHS Trust","startDate":"2003-11","conditions":["HIV Infections","Distal Symmetric Polyneuropathy"],"enrollment":50,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000179824","MMSL":"10540","NDDF":"003576","UNII":"6DH1W9VH8Q","VUID":"4029065","CHEBI":"CHEBI:73024","VANDF":"4018934","INN_ID":"6098","RXNORM":"193","UMLSCUI":"C0001040","ChEMBL_ID":"CHEMBL1358846","DRUGBANK_ID":"DB08842","PUBCHEM_CID":"7045767","SNOMEDCT_US":"329486002","MESH_DESCRIPTOR_UI":"D000108"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"10%"},"publicationCount":1235,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N06BX12","allCodes":["N06BX12"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"discontinued","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acetylcarnitine (ACETYLCARNITINE) is a carnitine analog, a small molecule drug class. It is used to treat Alzheimer's disease and senile dementia. The commercial status of Acetylcarnitine is unclear, but it has been approved for these indications. Key safety considerations include its low bioavailability of 10%. Further information on its half-life, generic manufacturers, and patent status is not available.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}